A pioneering step beyond PRP therapy, SPSCs tap into the body’s own rare regenerative potential for profound healing and tissue restoration
Eterna Health, in collaboration with internationally renowned regenerative medicine specialist Dr Adeel Khan, has introduced an advanced therapy harnessing Small Pluripotent Stem Cells (SPSCs) — marking a new frontier in the field of regenerative science that surpasses the traditional capabilities of Platelet-Rich Plasma (PRP).
While PRP has long been used to trigger healing through concentrated growth factors, SPSCs offer a far more complete and deeper form of regeneration. Present in small quantities within adult blood, these rare stem-like cells outperform PRP by not only signalling tissue repair but also directly regenerating damaged areas for more comprehensive recovery outcomes.
Collected from a standard blood sample, SPSCs measure less than five micrometres and express essential pluripotency markers such as OCT4, NANOG, SOX2 and SSEA-4 — evidence of their ability to differentiate into multiple tissue types. Using a proprietary cold-enrichment technique developed by Eterna Health’s laboratories, between 200 and 500 million viable SPSCs can be safely isolated from just 60 millilitres of blood. Their minuscule size allows them to circulate freely throughout the body rather than becoming trapped in the lungs, a limitation often observed with larger cells.
Preliminary clinical data indicates that SPSCs are both safe and highly promising, showing no tumour risk and demonstrating positive early results. This breakthrough signals the arrival of a next-generation regenerative tool that may redefine the standards of cellular therapy.
“PRP gives the body the signal to heal. SPSCs supply the mechanism,” stated Dr. Adeel Khan, CEO and Founder of Eterna Health. “By tapping into the body’s own regenerative capacity, we can now go beyond signalling and facilitate actual cellular repair and renewal in a safe, effective and natural way.”
The new therapy uses the patient’s own blood and is minimally manipulated, following the safety frameworks of regulatory agencies like the FDA and the EMA for regenerative medicine. This keeps the treatment biologically compatible and follows regulations, and it helps eliminate the risk of cultured cells or genetically modified stem cells.
Dr. Khan commented, “Safety, science and transparency are the cornerstone of everything we do. Our process is built upon solid biology and clinical standards, and a great respect for patient trust. SPSCs is the next step in the progression of responsible evidence-based regenerative care.”
Dr. Adeel Khan Md is a globally recognized authority in regenerative medicine and is well known for his leadership in applied cell therapy. He works with top athletes, longevity researchers, and internationally recognized health organizations to foster the safe and evidence-based use of stem-cell science. He is guiding Eterna Health to bridge the evolving regenerative landscape with clinical and patient-centred research to ensure new regenerative technologies are sound within a clinical context.
Dr. Khan and Eterna Health continue the important global conversation around responsible regenerative medicine that is ethical, and evidence based. The availability of this therapy adds to Eterna Health’s position as a leader in regenerative and functional medicine. By integrating academic rigor with patient-centred innovation, the clinic continues to provide accessible, ethical and effective therapies that harness the body’s innate ability to heal itself.
